Neogenomics Inc
NASDAQ:NEO

Watchlist Manager
Neogenomics Inc Logo
Neogenomics Inc
NASDAQ:NEO
Watchlist
Price: 16.245 USD -0.64% Market Closed
Market Cap: 2.1B USD
Have any thoughts about
Neogenomics Inc?
Write Note

Neogenomics Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Neogenomics Inc
Total Equity Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Neogenomics Inc
NASDAQ:NEO
Total Equity
$908.2m
CAGR 3-Years
-7%
CAGR 5-Years
13%
CAGR 10-Years
31%
Thermo Fisher Scientific Inc
NYSE:TMO
Total Equity
$49B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
9%
Danaher Corp
NYSE:DHR
Total Equity
$51.3B
CAGR 3-Years
6%
CAGR 5-Years
10%
CAGR 10-Years
8%
Mettler-Toledo International Inc
NYSE:MTD
Total Equity
-$152.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Agilent Technologies Inc
NYSE:A
Total Equity
$5.9B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
0%
IQVIA Holdings Inc
NYSE:IQV
Total Equity
$7B
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
N/A

See Also

What is Neogenomics Inc's Total Equity?
Total Equity
908.2m USD

Based on the financial report for Sep 30, 2024, Neogenomics Inc's Total Equity amounts to 908.2m USD.

What is Neogenomics Inc's Total Equity growth rate?
Total Equity CAGR 10Y
31%

Over the last year, the Total Equity growth was -4%. The average annual Total Equity growth rates for Neogenomics Inc have been -7% over the past three years , 13% over the past five years , and 31% over the past ten years .

Back to Top